drugset / Trial / NCT00813735

Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder

NCT00813735

RandomizedParallel-groupDouble-blindTreatment

Summary

Research has established the incidence of insomnia increases with age and the possible causes contributing to sleep problems in the elderly are still being explored and debated. Older adults use a disproportionately large share of sleep aids with non-prescription sleep aid use having increased over the past decade. This study is a double blind safety and effectiveness trial examining the response of eszopiclone co-administered with escitalopram for the treatment of insomnia symptoms in geriatric depressed adults with insomnia symptoms.

Timeline

Start
2006-09
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 2 mg
Background Escitalopram Small molecule 10 mg
Background Escitalopram Small molecule 20 mg

Indications